Allergic

The soluble guanylyl cyclase activator BAY 60-2770 inhibits murine allergic airways inflammation and human eosinophil chemotaxis.

Related Articles The soluble guanylyl cyclase activator BAY 60-2770 inhibits murine allergic airways inflammation and human eosinophil chemotaxis. Pulm Pharmacol Ther. 2016 Nov 2;: Authors: Baldissera L, Squebola-Cola DM, Calixto MC, Lima-Barbosa AP, Rennó AL, Anhê GF, Condino-Neto A, De…




Assessing the Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma and Allergic Rhinitis

Conditions:   Asthma, Allergic;   Rhinitis,Allergic;   AllergyInterventions:   Drug: Azelastine-Fluticasone Nasal;   Drug: PlacebosSponsor:   University of DundeeNot yet recruiting – verified October 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days




Evaluation of Tolerability and Safety of “Allergovac Poliplus” in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice

Conditions:   Allergic Rhinitis;   Rhinoconjunctivitis;   AsthmaIntervention:   Biological: Allergovac PoliplusSponsor:   BIAL Industrial Farmacéutica S.A.Not yet recruiting – verified July 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days




House dust mite immunotherapy in adults with allergic asthma – Pharmacy Today, American Pharmacists Association, pharmacist.com

Medscape House dust mite immunotherapy in adults with allergic asthmaPharmacy Today, American Pharmacists Association, pharmacist.comTaking house dust mite (HDM) sublingual allergen immunotherapy (SLIT) tablets in addition to maintenance medications appears to help reduce the risk of an attack in people…